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timated. Countries with the highest disease burdens are still not given the opportunity to contribute
adequately to the scientific field. Based on our data, relatively increasing publication activities include
those on respiratory infections, tuberculosis, malaria, hepatitis, and sepsis, whereas decreasing activi-
ties were determined for AIDS, diarrhoea, meningitis, schistosomiasis, and other diseases. Accordingly,
the prevalence of many infectious diseases occurring in tropical countries is not clearly reflected in the
worldwide publication activities.
DOI: https://doi.org/10.1016/j.ijmm.2005.12.015






The following work is licensed under a Creative Commons: Attribution-NonCommercial-NoDerivatives
4.0 International (CC BY-NC-ND 4.0) License.
Originally published at:
Becker, Katja; Hu, Ying; Biller-Andorno, Nikola (2006). Infectious diseases - a global challenge. Inter-
national Journal of Medical Microbiology : IJMM, 296(4-5):179-185.
DOI: https://doi.org/10.1016/j.ijmm.2005.12.015
International Journal of Medical Microbiology 296 (2006) 179–185
REVIEW
Infectious diseases – A global challenge
Katja Beckera,, Ying Hua, Nikola Biller-Andornob
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Abstract
Infectious diseases represent a continuous and increasing threat to human health and welfare. Due to emerging
diseases, increasing resistances, international travelling, and the risk of bioterroristic attacks, infectious diseases
concern the whole world and can only be combated by internationally coordinated and interdisciplinary approaches.
When assessing the worldwide publication activities on infectious diseases in the years 1994–2004 accessible via the ISI
Science Citation Index Expandeds, an overall increase by 24% can be monitored. Furthermore, it becomes evident
that highest research priorities are given to HIV/AIDS, hepatitis C, tuberculosis, respiratory infections, and sepsis. Ten
countries – including the USA, the UK, France, Germany, and Japan – contributed to more than 80% of these
publications; nation-specific research priorities focusing on the current problems in the respective country can be
estimated. Countries with the highest disease burdens are still not given the opportunity to contribute adequately to the
scientific field. Based on our data, relatively increasing publication activities include those on respiratory infections,
tuberculosis, malaria, hepatitis, and sepsis, whereas decreasing activities were determined for AIDS, diarrhoea,
meningitis, schistosomiasis, and other diseases. Accordingly, the prevalence of many infectious diseases occurring in
tropical countries is not clearly reflected in the worldwide publication activities.
r 2006 Elsevier GmbH. All rights reserved.
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Infectious diseases – current situation
Due to multiple drug resistances, migration of popula-
tions, and emerging pathogens infectious diseases repre-
sent a continuous and increasing threat to human health
and welfare. Despite the availability of antibiotics and
vaccines against many of the causative pathogens, the
mortality rates remain high. According to estimations of
the WHO, infectious diseases caused 14.7 million deaths
each in 2001, accounting for 26% of the total global
mortality (http://www.who.int). AIDS, tuberculosis, and
malaria furthermore range among the five major
obstacles to increased life expectancies (Feachem, 2004).
Infectious diseases are not only a problem of certain
areas in the world, although developing countries are
carrying the major part of the burden. As indicated by
the appearance and dissemination of the human
immunodeficiency virus and the outbreak of the severe
acute respiratory syndrome (SARS) (Krilov, 2004),
infectious diseases concern the whole world and can
only be solved by internationally coordinated and
interdisciplinary approaches. In order to enable and
facilitate the long-term control of infectious diseases,
molecular biologists, biochemists and pharmacologists
have to collaborate closely with physicians, epidemiolo-
gists and public health researchers in order to insure the
transfer and application of scientific data to the field. In
parallel, governmental institutions have to collaborate
with private funding partners and industrial partners
without losing influence on the research agenda. Control
of infections can only be successful if priority is given to
combating the individual suffering and its structural and
socioeconomic causes rather than to serving political or
economic interests (Perkins, 2004; Becker et al., 2003).
In order to better understand how we are positioned to
meet the global challenge of infectious diseases and to make
a real difference in the burden of disease, we looked at three
issues: (1) What countries contribute most to what we know
about infectious diseases? Do results still come from rich
countries or are developing countries starting to have a
voice in the international scientific literature? (2) By what
criteria do researchers evaluate their peers’ work? Do they
rely on scientific quality only or do they also consider
efforts to bridge the gap between research and application?
(3) What contributions to infectious disease research are
considered most important? Do researchers mainly think
about classical landmark papers or rather about basic
research or papers that had impact in terms of shaping
public health policy or improving the health of populations?
Publication activities on infectious diseases are
still dominated by industrial countries
In order to learn more about the worldwide contribu-
tions to infectious disease research, we assessed the
publication activities of different countries in the years
1994–2004 which were accessible via the ISI WebPages
(http://isi02.isiknowledge.com/portal.cgi?DestApp=
WOS&Func=Frame). The database used is Science
Citation Index Expanded (SCI-EXPANDED).
The 22 infectious diseases which – according
to the estimations of the World Health Organization –
caused more than 5000 deaths each in 2002 worldwide





Since for the key word ‘‘maternal sepsis’’ only few hits
were found in the database and since research on sepsis
contributes scientifically also to the field of maternal sepsis,
we decided to use the key word ‘‘sepsis’’ for our study.
The five countries with the highest publication
activities over the last 10 years – as deduced from the
data we obtained – were then chosen to assess the
national research activities in the different fields of
infectious diseases.
Our literature search yielded the following results:
Between 1994 and 2004 more than 5% of the articles
listed in the Medline database addressed the 22
infectious diseases we had selected for our sample. The
total number of articles on these diseases increased from
51,267 published in the years 1994 and 1995 to 63,983
published in the years 2002 and 2003. Ten countries
contributed to more than 80% of these publications.
The 15 countries with the highest publication activities
are listed in Table 1. The top five countries are USA,
UK, France, Germany, and Japan. When analyzing the
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Table 1. Ranking of different countries based on their
contribution to publications in the field of infectious diseases
between 1994 and 2004
Rank Country Number of articles Percentage
1 USA 127,978 39.87
2 UK 34,369 10.71
3 France 26,060 8.12
4 Germany 20,622 6.42
5 Japan 17,828 5.55
6 Italy 16,131 5.03
7 Spain 11,454 3.57
8 Canada 11,076 3.45
9 The Netherlands 8340 2.60
10 Switzerland 8192 2.55
11 Australia 8063 2.51
12 Brazil 6506 2.03
13 India 6386 1.99
14 Belgium 5800 1.81
15 Sweden 5397 1.68
Data collected from the ISI Science Citation Index Expanded.
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contributions of the different countries to the publica-
tions over the last 10 years, USA and France show a
decreasing trend (since the overall number of publica-
tions on the selected diseases is increasing), the UK is
stable, and Germany as well as Japan show increasing
trends (for all trends Po0:05 according to the Cochran-
Armitage Trend Test).
Our results concerning the ranking and developments
of publication activities by countries are comparable to
data reported by Takahashi et al. (2002), who analyzed
the contribution of different countries to articles related
to infectious diseases and published in selected journals.
Whereas the share of articles from USA and Canada
went down, the percentage of articles published by
groups from Italy, Spain, and Brazil increased (Takaha-
shi et al., 2002). As our analysis shows, Brazil and India
are among the top 15 countries when taking the last 10
years into account. Once developing countries start to
be among those who are highly active in the area of
infectious disease research, chances are better that they
will in fact participate fully in shaping the research
agenda. Well-known experts from developing countries
that have published in high-impact journals are certainly
instrumental for reminding the scientific community as
well as political and economic leaders of the so-called
10–90 gap indicating that less than 10% of the global
health research resources are allocated to the health
problems of developing countries, which account for
over 90% of the world’s health problems (http://www.
globalforumhealth.org/site/003__The%2010%2090%20
gap/001__Now.php).
Research priorities vary among different
countries
As indicated in Fig. 1, over the last 10 years greatest
attention has been given to HIV/AIDS-related research.
Worldwide high priority has also been given to
respiratory diseases, tuberculosis, and hepatitis C. This
group of diseases is followed by sepsis, hepatitis B,
diarrhoea, and malaria. It is notable to see that although
diarrhoea and malaria represent the third and fifth most
frequent causes of death worldwide they only rank on
positions 7 and 8, respectively, in the research priorities.
It might be speculated that one of the reasons for this
constellation is the fact that these diseases seem to be
less threatening for industrial countries.
Based on our data, publications on respiratory
infections, tuberculosis, malaria, hepatitis B and C,
sepsis, Dengue fever, Chagas’ disease, Japanese ence-
phalitis, and chlamydial infections increased over the
last 10 years. Unfortunately, a decrease in worldwide
publication activities was determined for AIDS, diar-
rhoea, pertussis, tetanus, meningitis, syphilis, schistoso-
miasis, leprosy, and diphtheria. Publications on measles,
leishmaniasis and trypanosomiasis did not change
remarkably (Cochran-Armitage Test for Trend,
P40:05 for all trends described).
The emergence of microbes resistant to antibiotics is
considered to be a most serious threat to humanity
(Hacker and Klenk, 2005). This fact is also reflected by
the worldwide publication activities on drug resistance
which more than doubled over the last 10 years.
The five countries with the highest publication
activities were then in our study chosen for further
analysis to assess the national research activities
in the different fields of infectious diseases. In most
countries, HIV/AIDS research is given the highest
priority. In the USA (Fig. 2A) this is followed by
respiratory diseases; for hepatitis C a strong increase can
be monitored. A similar pattern becomes evident for
France (data not shown). In the UK (Fig. 2B), HIV/
AIDS, tuberculosis, and malaria research are particu-
larly strong. In Germany – apart from HIV/AIDS
research – priority is given to sepsis and hepatitis C
research followed by respiratory infections (data not
shown). In contrast, Japan focuses on hepatitis C
followed by HIV/AIDS, respiratory infections and
hepatitis B.
When we look at the development of research
priorities over the last decade (Fig. 1) it is obvious that
the burden of disease is certainly not the only factor in
determining research intensity. For instance, the fact
that diarrhoeal diseases are among the three most severe
health problems (http://www.who.int) is not clearly
reflected in worldwide publication activities. The top
five countries with most publication activities on
infectious diseases each seem to focus on diseases that
are relevant within their own borders, like hepatitis B
and C, sepsis, and HIV/AIDS. Countries with a colonial
past, like the UK, seem to put more emphasis on
diseases like malaria that are of particular relevance to
developing countries.
The experts’ view
In order to facilitate the interpretation of the
statistical data and add some qualitative aspects to the
quantitative analyses, we addressed senior scientists in
the field of infectious diseases in autumn 2004 and
sought their written opinion on the perception of
infectious disease research and strategies that should
be undertaken in the future. As a result, the input of 78
experienced group leaders (28% from Germany, 5%
each from India, Switzerland, UK, and USA, 1–4%
from 27 other countries in the world) could be included
into this work. Of these 78 scientists, 32% declared that
their main field of current research was virology, for
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Fig. 2. The number of articles on selected infectious diseases published between 1994 and 2003 in the USA (A) and the UK (B). The
15 most important infectious diseases were included in this figure. *The search key word for ‘‘HIV/AIDS’’ was chosen as described
in the legend of Fig. 1; the number of articles on ‘‘HIV OR AIDS’’ in the graph has to be multiplied by 3. The search key word for











































Fig. 1. The number of articles on selected infectious diseases and antibiotic resistance published between 1994 and 2003 worldwide.
The 15 most important infectious diseases were included in this figure. *The search key word for ‘‘HIV/AIDS’’ was ‘‘(acquired
immunodeficiency syndrome) OR (acquired immune deficiency syndrome) OR (HIV) OR (human immunodeficiency virus) OR
(human immune deficiency virus)’’. The number of articles on ‘‘HIV OR AIDS’’ in the graph has to be multiplied by 3. The search
key word for ‘‘diarrhoeal disease’’ was ‘‘diarrhoea’’; the search key word for ‘‘maternal sepsis’’ was ‘‘sepsis’’.
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31% it was bacteriology, for 27% parasitology, and for
the remaining 10% mycology or combined fields.
According to the opinion of these scientists, research
priorities within the next years should be given to
virology followed directly by bacteriology and then
parasitology and mycology. As major source of current
funding of the respective groups, the government was
listed in 78% of the cases, private funding in 27%. As
the most essential factors determining the excellence of
infectious disease research were regarded funding
(90%), scientific exchange (76%), education (64%),
connection between the laboratory and the field
(55%), and the country in which the research is carried
out (55%).
USA, UK, France, and Germany were regarded to be
leading in the field of infectious diseases. This impres-
sion was in accordance with the statistical data obtained
on publication activity within the frame of this study
(see above). An interesting contribution to this phenom-
enon has recently been made by Man et al. (2004).
According to their study, research funding and English
proficiency are strongly associated with publication
output in the highest ranked general medical journals.
Table 2 shows the most reliable evaluation criteria for
a research group working on infectious diseases as
judged by the scientists. High priority was given to
‘‘Originality’’ and ‘‘Impact factors’’ of the journals the
respective articles are published in (concerning the use
and misuse of impact factors in evaluating research, see,
e.g. Seglen, 1997). ‘‘Applicability of the results to the
field/clinical work’’ was ranked third, having been
chosen by about one-third of the scientists as one of
the three most reliable criteria for evaluating a research
group. ‘‘Interdisciplinarity’’ and ‘‘Impact on policy’’
were chosen by less then 15%.
Considering the challenges that lie ahead – part of
which are developing and implementing programs to
treat diseases where the causative agents are known and
therapies already exist – it seems that an effective
infectious diseases research team would also be mea-
sured by its impact on policy-making and its inter-
disciplinary approach. However, both factors have been
largely dismissed by the researchers. Applicability to the
field and to clinical work, which would seem important
given current challenges, was mentioned third by a
distance after originality and impact factor. The
relatively low priority that was given to impact on
policies, interdisciplinarity and applicability can be
understood from a purely scientific point of view. In
addition, the answers we obtained were certainly biased
by the fact that most scientists whose answers are
summarized here were from Western industrialized
countries. To investigate this phenomenon systemati-
cally, further studies would be required. However, the
tendency of many scientists to refrain from the transfer
of their results and the health policy arena might be one
of the reasons why many programs directed against
infectious diseases are less successful in reducing the
global mortality and burden than they could be.
Apart from the results of our study and political as
well as economic strategies, a number of central
strategies for efficient control of infectious diseases have
to be followed in the future. As concluded at the
International Symposium ‘‘Threat of Infection’’, con-
ducted in Würzburg, Germany, in July 2004 (Hacker
and Klenk, 2005), these include (i) maintainance of
vaccination programs and development of novel vac-
cines, (ii) preservation of the know-how concerning
pathogens and diseases which are considered to be in the
post-eradication era (like smallpox) in order to be
prepared for reappearance of the pathogens and
potential bioterroristic attacks, (iii) guaranteed provi-
sion of vaccines and drugs for emergencies, (iv)
prevention of misuse of know-how, methods, and drugs
by increasing national and international security mea-
sures, (v) enhanced interdisciplinary research activities
including genome and proteome analyses, characteriza-
tion of known and novel pathogens, studies on
mechanisms of transmission, pathogenicity, and resis-
tance as well as drug development including all required
preclinical and clinical steps.
The pioneers’ work still has the highest impact
Furthermore, we asked the 78 experts which 10
scientific publications were regarded to be the most
important ones in the field of infectious diseases.
The most frequently mentioned works are listed in
Table 3. In addition to those, the following scientific
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Applicability of results in field/clinic 37
Continuity of research 33
Number of publications 27
Citation index 27
Training of young scientists 23
Interdisciplinarity 12
Funding profile 12
Impact on policy 8
Patents 4
Academic prizes 3
According to the opinion of 78 senior scientists these criteria were
regarded to be reliable for evaluating a research group working on
infectious diseases. Three criteria were supposed to be chosen out of
the 12 given.
aConcerning the use and misuse of impact factors in evaluating
research, see e.g. Seglen, 1997.
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contributions were quoted repeatedly: John Franklin
Enders – isolation of the poliovirus, Alphonse Laveran –
discovery of the human malaria parasite, Kary Banks
Mullis – development of PCR, Pierre Paul Émile Roux –
development of the diphtheria vaccine, Jonas Salk –
poliomyelitis vaccination, James Watson and Francis
Crick – discovery of DNA, and the conduction of
genome projects by different authors.
As shown in Table 3, highest credits were given to the
pioneers of infectious disease research, whereas the more
recent advances did not receive high attention. However,
to tackle the global challenge that infectious diseases
confront us with today, we need answers that go beyond
the identification of micro-organisms and therapeutic or
preventive principles that Pasteur, Fleming, Jenner,
Koch, Ehrlich, Ross, and von Behring provided us
with. Beyond these fundamental and important dis-
coveries we need contextual knowledge about socio-
economic, political and cultural factors in order to tailor
treatment and prevention programs that will work.
In doing so we will also need to take into account
ethical issues. Some of the classic researches on vaccines
and chemotherapeutic agents aroused moral suspicion
and debate already when it was conducted in the late
19th and early 20th century. Studies, among them
Robert Koch’s and Paul Ehrlich’s experiments with
Salvarsan and other chemicals, were criticized for
insufficient informed consent of study participants and
for using vulnerable populations, like people living in
‘‘the colonies’’, prisoners, children, or prostitutes (Reu-
land, 2004; Roelcke and Maio, 2004). The guidelines of
the German Reich’s Ministry of the Interior of 1930
reacted to the increasingly intense political debate by
specifically emphasizing the necessity of explicit in-
formed consent und the moral inadequacy of exploiting
a person’s difficult social situation for performing
studies that pose a risk to the participant’s health
(Steinmann, 1975). Since then, ethical standards have
been further elaborated and laid down in international
guidelines, like the Nuremberg Code (1947), the
Declaration of Helsinki (1964/2000), and the CIOMS
International guidelines on research involving human
subjects (2002). When building research capacity in
developing countries and intensifying efforts to meet the
global challenge of infectious diseases today, we need to
make sure that ambition, greed, or even the genuine
wish to alleviate and prevent suffering do not compro-
mise these ethical principles that have been agreed on
worldwide. It is true that not all questions regarding
research ethics have already been settled. Particularly
clinical trials that include some form of collaboration
between rich countries and developing countries are
raising issues, like permissible standards of care for
control groups and after-trial obligations, that need to
be addressed in a fair and transparent manner.
Conclusions
In conclusion, overall increase in publication activities
on infectious diseases during the last 10 years is a very
promising sign. However, concerning research priorities,
the scientific community should focus on the most
prominent diseases affecting large parts of the world’s
population like diarrhoeal diseases and malaria, but also
on neglected diseases like schistosomiasis and trypano-
somiasis. Taking into account that national research
activities are of course driven by national funding this is
a difficult task. Based on the publication activities, the
countries with the highest infectious disease burdens are
still not given the opportunity to contribute adequately
to the scientific field. More political engagement of the
scientific community might help to overcome this
problem in the long term. According to our survey,
the pioneer discoveries in infectious diseases still have
the greatest impact; most of these pioneer studies were
directly related to (chemo)therapy, prophylaxis or
aetiology indicating that applied research is still
considered most important.
As delineated above, there is no doubt that good basic
research is needed in order to reduce the global
mortality and global burden of infectious diseases. But
beyond basic research intense efforts are needed to
translate these findings into the realm of public policy
and public health. And sometimes, mere translation will
not be enough. In order to really make a difference we
will continuously have to check if our research agenda
responds to the most pressing needs rather than to the
biggest markets. In order to actually tackle the global
challenge of infectious diseases we need to find the best
and most efficient ways to transfer knowledge from the
labs to the field. As developing countries are the ones for
whom the burden of disease is greatest, their participa-
tion in the definition of research goals and the
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Table 3. The most important contributions to infectious
diseases research as judged by 78 senior scientists in the field in
autumn 2004
Rank Name Contribution
1 Louis Pasteur Founder of microbiology,
immunization
2 Alexander Fleming Discovery of penicillin
3 Edward Jenner Vaccination against smallpox
4 Robert Koch Etiology of and vaccination
against tuberculosis,
microscopy
5 Paul Ehrlich Chemotherapy against
infectious diseases
6 Ronald Ross Link between mosquitoes and
malaria
7 Emil von Behring Discovery of antitoxin
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implementation of results is essential. Clinical trial
partnerships between rich and developing countries are
an important step in that direction (cf. for example the
European & Developing Countries Clinical Trials
Partnership, http://www.edctp.org/). We will have to
make sure, however, that blind enthusiasm or conflicts
of interest do not compromise the ethical dimension of
an urgently needed global effort to reduce mortality and
burden of infectious diseases.
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